Experts expressed enthusiasm Friday after US health regulators approved the first new form of treatment for schizophrenia in ...

Cobenfy doesn’t have the same severe side effects as older schizophrenia medications — like weight gain, involuntary muscle ...

The U.S. Food and Drug Administration (FDA) on Thursday approved the first new drug to treat people with schizophrenia in ...

On Thursday, the Food and Drug Administration approved Cobenfy, a drug from Bristol Myers Squibb—the first truly novel ...

This suggests the need for psychiatric treatment drugs, not stomach drugs, and it is the beginning of a chronic disease stage. In oriental medicine, ‘functional dyspepsia’ is called ‘phlegm retention ...

The U.S. Food and Drug Administration (FDA) on Thursday approved Bristol Myers Squibb’s (BMY) highly anticipated ...

Without proper treatment and prevention, GERD can cause damage to the esophagus. Although over-the-counter and prescription ...

New schizophrenia treatment Cobenfy approved by US regulators, offering hope for millions with fewer side effects.

Whether it's a treatment grandma recommended or one your best friend tells you ... 11 by the medical journal MBJ, researchers reported they found early signs of turmeric's success in managing ...

U.S. FDA Approves Bristol Myers Squibb’s COBENFY, a First-In-Class Muscarinic Agonist for the Treatment of Schizophrenia in Adults ...

Biotin and collagen are nutrients that support hair, skin, nail, and bone health. A healthcare provider may suggest taking ...

Leaky gut syndrome is believed to be the result or cause of some chronic conditions. Learn how symptoms may have to do with ...